Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Thakur, Archana ^a   Bollig, Aliccia ^a   Wu, Jiusheng ^a   Liao, Dezhong J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYC PROTEIN; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 1; WT1 PROTEIN; MYC PROTEIN, MOUSE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CANCER; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROGNOSIS; PROTEIN EXPRESSION; RNA BINDING; RNA EDITING; RNA PROCESSING; RNA SPLICING; SPLICEOSOME; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; ONCOGENE MYC; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, MYC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 40349096475     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-11     Document Type: Article

References (57)

1. Yeo TP Hruban RH Leach SD Wilentz RE Sohn TA Kern SE Iacobuzio-Donahue CA Maitra A Goggins M Canto MI Pancreatic cancer Curr Probl Cancer 2002, 26(4):176-275. 12399802 10.1067/mcn.2002.129579
2. Schleger C Verbeke C Hildenbrand R Zentgraf H Bleyl U c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance Mod Pathol 2002, 15(4):462-469. 11950922 10.1038/modpathol.3880547
3. Mahlamaki EH Barlund M Tanner M Gorunova L Hoglund M Karhu R Kallioniemi A Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer Genes Chromosomes Cancer 2002, 35(4):353-358. 12378529 10.1002/gcc.10122
4. Yamada H Sakamoto H Taira M Nishimura S Shimosato Y Terada M Sugimura T Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes Jpn J Cancer Res 1986, 77(4):370-375. 3009377
5. Sandgren EP Quaife CJ Paulovich AG Palmiter RD Brinster RL Pancreatic tumor pathogenesis reflects the causative genetic lesion Proc Natl Acad Sci USA 1991, 88(1):93-97. 1986386 10.1073/pnas.88.1.93 50755
6. Liao DJ Wang Y Wu J Adsay NV Grignon D Khanani F Sarkar FH Characterization of pancreatic lesions from MT-tgfalpha, Ela-myc and MT-tgfalpha/Ela-myc single and double transgenic mice J Carcinog 2006, 5:19. 16822304 10.1186/1477-3163-5-19 1559682
7. Liao JD Adsay NV Khannani F Grignon D Thakur A Sarkar FH Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer Histol Histopathol 2007, 22(6):661-676. 17357096
8. Keleg S Buchler P Ludwig R Buchler MW Friess H Invasion and metastasis in pancreatic cancer Mol Cancer 2003, 2:14. 12605717 10.1186/ 1476-4598-2-14 149416
9. Kleeff J Friess H Berberat PO Martignoni ME Z'Graggen K Buchler MW Pancreatic cancer - new aspects of molecular biology research Swiss Surg 2000, 6(5):231-234. 11077487 10.1024/1023-9332.6.5.231
10. Iacobuzio-Donahue CA Maitra A Olsen M Lowe AW van Heek NT Rosty C Walter K Sato N Parker A Ashfaq R Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 2003, 162(4):1151-1162. 1851213 12651607
11. Iacobuzio-Donahue CA Maitra A Shen-Ong GL van Heek T Ashfaq R Meyer R Walter K Berg K Hollingsworth MA Cameron JL Discovery of novel tumor markers of pancreatic cancer using global gene expression technology Am J Pathol 2002, 160(4):1239-124. 91867224 11943709
12. Maacke H Jost K Opitz S Miska S Yuan Y Hasselbach L Luttges J Kalthoff H Sturzbecher HW DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma Oncogene 2000, 19(23):2791-2795. 10851081 10.1038/sj.onc.1203578
13. Lynch HT Deters CA Snyder CL Lynch JF Villeneuve P Silberstein J Martin H Narod SA Brand RE BRCA1 and pancreatic cancer: Pedigree findings and their causal relationships Cancer Genet Cytogenet 2005, 158(2):119-125. 15796958 10.1016/j.cancergencyto.2004.01.032
14. Mahlamaki EH Kauraniemi P Monni O Wolf M Hautaniemi S Kallioniemi A High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer Neoplasia 2004, 6(5):432-439. 15548351 10.1593/neo.04130 1550328
15. Nakamura T Fidler IJ Coombes KR Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment Cancer Res 2007, 67(1):139-148. 17210693 10.1158/0008-5472.CAN-06-2563
16. Nakamura T Furukawa Y Nakagawa H Tsunoda T Ohigashi H Murata K Ishikawa O Ohgaki K Kashimura N Miyamoto M Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection Oncogene 2004, 23(13):2385-2400. 14767473 10.1038/ sj.onc.1207392
17. Soling A Sackewitz M Volkmar M Schaarschmidt D Jacob R Holzhausen HJ Rainov NG Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma Clin Cancer Res 2005, 11(1):249-258. 15671553
18. Sanada Y Oue N Mitani Y Yoshida K Nakayama H Yasui W Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype J Pathol 2006, 208(5):633-642. 16435283 10.1002/path.1922
19. Yonezawa S Byrd JC Dahiya R Ho JJ Gum JR Griffiths B Swallow DM Kim YS Differential mucin gene expression in human pancreatic and colon cancer cells Biochem J 1991, 276(Pt 3):599-605. 1151047 2064602
20. Hollingsworth MA Swanson BJ Mucins in cancer: Protection and control of the cell surface Nat Rev Cancer 2004, 4(1):45-60. 14681689 10.1038/ nrc1251
21. Resar LM Dolde C Barrett JF Dang CV B-myc inhibits neoplastic transformation and transcriptional activation by c-myc Mol Cell Biol 1993, 13(2):1130-1136. 358997 8423780
22. Griffith OL Melck A Jones SJ Wiseman SM Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers J Clin Oncol 2006, 24(31):5043-5051. 17075124 10.1200/JCO.2006.06.7330
23. Moore LE Fung ET McGuire M Rabkin CC Molinaro A Wang Z Zhang F Wang J Yip C Meng XY Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population Cancer Epidemiol Biomarkers Prev 2006, 15(9):1641-1646. 16985025 10.1158/1055-9965.EPI-05-0980
24. Weinstein PS Skinner M Sipe JD Lokich JJ Zamcheck N Cohen AS Acute-phase proteins or tumour markers: The role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases Scand J Immunol 1984, 19(3):193-198. 6200925
25. Sato N Fukushima N Maitra A Iacobuzio-Donahue CA van Heek NT Cameron JL Yeo CJ Hruban RH Goggins M Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas Am J Pathol 2004, 164(3):903-914. 1613263 14982844
26. Lian Z De Luca P Di Cristofano A Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer J Cell Physiol 2006, 208(2):255-266. 16688764 10.1002/jcp.20681
27. Liu AY Zhang H Sorensen CM Diamond DL Analysis of prostate cancer by proteomics using tissue specimens J Urol 2005. 173(1):73-78. 15592032
28. Mauri P Scarpa A Nascimbeni AC Benazzi L Parmagnani E Mafficini A Della Peruta M Bassi C Miyazaki K Sorio C Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: A strategy for identification of novel cancer markers Faseb J 2005, 19(9):1125-1127. 15985535
29. Hansel DE Rahman A House M Ashfaq R Berg K Yeo CJ Maitra A Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms Clin Cancer Res 2004, 10(18 Pt 1):6152-6158. 15448002 10.1158/1078-0432.CCR-04-0285
30. Karna E Surazynski A Orlowski K Laszkiewicz J Puchalski Z Nawrat P Palka J Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer Int J Exp Pathol 2002, 83(5):239-245. 12641820 10.1046/ j.1365-2613.2002.00237.x
31. Zumkeller W IGFs and IGFBPs: Surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol 2001, 54(5):285-288. 11577168 10.1136/mp.54.5.285 1187083
32. Yamada S Ohira M Horie H Ando K Takayasu H Suzuki Y Sugano S Hirata T Goto T Matsunaga T Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas Oncogene 2004, 23(35):5901-5911. 15221005 10.1038/sj.onc.1207782
33. Johnson JM Castle J Garrett-Engele P Kan Z Loerch PM Armour CD Santos R Schadt EE Stoughton R Shoemaker DD Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays Science 2003, 302(5653):2141-2144. 14684825 10.1126/science.1090100
34. Pajares MJ Ezponda T Catena R Calvo A Pio R Montuenga LM Alternative splicing: An emerging topic in molecular and clinical oncology Lancet Oncol 2007, 8(4):349-357. 17395108 10.1016/S1470-2045(07)70104-3
35. Srebrow A Kornblihtt AR The connection between splicing and cancer J Cell Sci 2006, 119(Pt 13):2635-2641. 16787944 10.1242/jcs.03053
36. Venables JP Aberrant and alternative splicing in cancer Cancer Res 2004, 64(21):7647-7654. 15520162 10.1158/0008-5472.CAN-04-1910
37. Brinkman BM Splice variants as cancer biomarkers Clin Biochem 2004, 37(7):584-594. 15234240 10.1016/j.clinbiochem.2004.05.015
38. Hayes GM Carrigan PE Beck AM Miller LJ Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma Cancer Res 2006, 66(7):3819-3827. 16585209 10.1158/0008-5472.CAN-05-4065
39. Zahler AM Neugebauer KM Lane WS Roth MB Distinct functions of SR proteins in alternative pre-mRNA splicing Science 1993, 260(5105):219-222. 8385799 10.1126/science.8385799
40. Stickeler E Kittrell F Medina D Berget SM Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis Oncogene 1999, 18(24):3574-3582. 10380879 10.1038/sj.onc.1202671
41. Bailis JM Forsburg SL MCM proteins: DNA damage, mutagenesis and repair Curr Opin Genet Dev 2004, 14(1):17-21. 15108800 10.1016/j.gde.2003.11.002
42. Hirano T At the heart of the chromosome: SMC proteins in action Nat Rev Mol Cell Biol 2006, 7(5):311-322. 16633335 10.1038/nrm1909
43. Amor DJ Kalitsis P Sumer H Choo KH Building the centromere: From foundation proteins to 3D organization Trends Cell Biol 2004, 14(7):359-368. 15246429 10.1016/j.tcb.2004.05.009
44. Khanna KK Jackson SP DNA double-strand breaks: Signaling, repair and the cancer connection Nat Genet 2001, 27(3):247-254. 11242102 10.1038/85798
45. Kataoka H Itoh H Koono M Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration Pathol Int 2002, 52(2):89-102. 11940213 10.1046/ j.1440-1827.2002.01320.x
46. Firth SM Baxter RC Cellular actions of the insulin-like growth factor binding proteins Endocr Rev 2002, 23(6):824-854. 12466191 10.1210/ er.2001-0033
47. Perks CM Newcomb PV Norman MR Holly JM Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells J Mol Endocrinol 1999, 22(2):141-150. 10194517 10.1677/jme.0.0220141
48. Jones JI Doerr ME Clemmons DR Cell migration: Interactions among integrins, IGFs and IGFBPs Prog Growth Factor Res 1995, 6(2-4):319-327. 8817675 10.1016/0955-2235(95)00015-1
49. Petrache I Fijalkowska I Zhen L Medler TR Brown E Cruz P Choe KH Taraseviciene-Stewart L Scerbavicius R Shapiro L A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema Am J Respir Crit Care Med 2006, 173(11):1222-1228. 16514110 10.1164/ rccm.200512-1842OC
50. Zelvyte I Wallmark A Piitulainen E Westin U Janciauskiene S Increased plasma levels of serine proteinase inhibitors in lung cancer patients Anticancer Res 2004, 24(1):241-247. 15015603
51. Trichopoulos D Tzonou A Kalapothaki V Sparos L Kremastinou T Skoutari M Alpha 1-antitrypsin and survival in pancreatic cancer Int J Cancer 1990, 45(4):685-686. 2323846 10.1002/ijc.2910450419
52. Tzonou A Sparos L Kalapothaki V Zavitsanos X Rebelakos A Trichopoulos D Alpha 1-antitrypsin and survival in hepatocellular carcinoma Br J Cancer 1990, 61(1):72-73. 2153397
53. Higashiyama M Doi O Kodama K Yokouchi H Tateishi R An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: An immunohistochemical analysis Br J Cancer 1992, 65(2):300-302. 1739634
54. Sun Z Yang P Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression Lancet Oncol 2004, 5(3):182-190. 15003202 10.1016/S1470-2045(04)01414-7
55. Higashiyama M Doi O Kodama K Yokouchi H Tateishi R Matsuura N Murata A Tomita N Monden T Ogawa M Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: Its possible participation in scar formation of the tumor tissues Tumour Biol 1992, 13(5-6):299-307. 1290027
56. Thakur A Xu H Wang Y Bollig A Biliran H Liao JD The role of X-linked genes in breast cancer Breast Cancer Res Treat 2005, 93(2):135-143. 16187233 10.1007/s10549-005-4516-0
57. Oji Y Nakamori S Fujikawa M Nakatsuka S Yokota A Tatsumi N Abeno S Ikeba A Takashima S Tsujie M Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma Cancer Sci 2004, 95(7):583-7. 15245594 10.1111/j.1349-7006.2004.tb02490.x